FY2024 Earnings Estimate for ACHC Issued By Leerink Partnrs

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Leerink Partnrs cut their FY2024 earnings per share (EPS) estimates for shares of Acadia Healthcare in a report issued on Friday, November 1st. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $3.42 per share for the year, down from their prior estimate of $3.50. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.97 EPS and Q3 2025 earnings at $0.95 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 earnings per share.

Other equities analysts also recently issued research reports about the company. KeyCorp began coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Barclays lowered their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Monday. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $86.67.

Acadia Healthcare Trading Up 0.7 %

Shares of Acadia Healthcare stock opened at $42.33 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.07. Acadia Healthcare has a 52 week low of $41.42 and a 52 week high of $87.77. The stock has a 50 day moving average price of $65.72 and a two-hundred day moving average price of $67.75. The stock has a market capitalization of $3.93 billion, a PE ratio of 13.88, a price-to-earnings-growth ratio of 1.28 and a beta of 1.33.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. GAMMA Investing LLC raised its position in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the last quarter. Blue Trust Inc. lifted its position in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the period. Commonwealth Equity Services LLC boosted its holdings in Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the last quarter. Atria Investments Inc raised its stake in Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the last quarter. Finally, Crossmark Global Holdings Inc. lifted its holdings in shares of Acadia Healthcare by 6.6% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 7,077 shares of the company’s stock valued at $449,000 after buying an additional 440 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.